Patient and Device Selection in Pediatric MCS: A Review of Current Consensus and Unsettled Questions

被引:8
|
作者
Friedland-Little, Joshua M. [1 ]
Joong, Anna [2 ]
Shugh, Svetlana B. [3 ]
O'Connor, Matthew J. [4 ]
Bansal, Neha [5 ]
Davies, Ryan R. [6 ]
Ploutz, Michelle S. [7 ]
机构
[1] Univ Washington, Seattle Childrens Hosp, Div Cardiol, Seattle, WA 98195 USA
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiol, Chicago, IL 60611 USA
[3] Joe DiMaggio Childrens Hosp, Heart Inst, Hollywood, FL USA
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Albert Einstein Coll Med, Div Pediat Cardiol, Childrens Hosp Montefiore, Bronx, NY 10467 USA
[6] UT Southwestern Med Ctr & Childrens Hlth, Dallas, TX USA
[7] Univ Utah, Salt Lake City, UT USA
关键词
Pediatric; Heart failure; Ventricular assist device; Mechanical circulatory support; VENTRICULAR ASSIST DEVICE; BERLIN HEART EXCOR; TOTAL ARTIFICIAL-HEART; RESTRICTIVE CARDIOMYOPATHY; CIRCULATORY SUPPORT; INTERAGENCY REGISTRY; IMPROVING OUTCOMES; IMPELLA DEVICE; TRANSPLANTATION; MULTICENTER;
D O I
10.1007/s00246-022-02880-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The field of pediatric ventricular assist device (VAD) support has expanded significantly over the past 20 years, with one third of pediatric heart transplant recipients currently being bridged to transplant with a VAD. Despite increased pediatric VAD utilization, however, there remains little formalized guidance for patient or device selection. The population of children with advanced heart failure is quite heterogeneous, and the available data suggest that VAD outcomes vary significantly based upon patient size, anatomy, level of illness, and type of device implanted. In an effort to better understand current practice patterns and identify populations for whom there does not appear to be a consensus approach to achieving optimal VAD outcomes, the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) has surveyed clinical decision-making among member sites and conducted a review of the available literature regarding patient population-specific VAD outcomes and center-specific practices related to patient and device selection. Rather than aiming to provide clinical guidelines, this document offers an overview of contemporary approaches to patient and device selection, highlighting specific populations for whom there is not a consensus approach to achieving reliably good VAD outcomes, as these populations may benefit most from future research and quality improvement efforts directed toward identifying best practice.
引用
收藏
页码:1193 / 1204
页数:12
相关论文
共 46 条
  • [41] EVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY
    Ratti, Maria Monica
    Gandaglia, Giorgio
    Leardini, Luca
    Ferracini, Serena Mazzoleni
    Sisca, Elena Silvia
    Derevianko, Alexandra
    Furnari, Silvia
    Beyer, Katharina
    Pellegrino, Francesco
    Sorce, Gabriele
    Scuderi, Simone
    Barletta, Francesco
    Cucchiara, Vito
    Omar, Muhammad Imran
    Maclennan, Steven
    Zong, Jihong
    Maclennan, Sara J.
    Aiyegbusi, Olalekan Lee
    Van Hemelrijck, Mieke
    N'Dow, James
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2021, 206 : E212 - E212
  • [42] A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology
    Ratti, Maria Monica
    Gandaglia, Giorgio
    Sisca, Elena Silvia
    Derevianko, Alexandra
    Alleva, Eugenia
    Beyer, Katharina
    Moss, Charlotte
    Barletta, Francesco
    Scuderi, Simone
    Omar, Muhammad Imran
    MacLennan, Steven
    Williamson, Paula R.
    Zong, Jihong
    MacLennan, Sara J.
    Mottet, Nicolas
    Cornford, Philip
    Aiyegbusi, Olalekan Lee
    Van Hemelrijck, Mieke
    N'Dow, James
    Briganti, Alberto
    CANCERS, 2022, 14 (20)
  • [43] Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection (vol 14, pg 4819, 2021)
    LeVee, A.
    Lin, C. Y.
    Posadas, E.
    ONCOTARGETS AND THERAPY, 2021, 14 : 5167 - 5167
  • [44] Evaluation of patient-reported outcome measures of functional recovery following caesarean section: a systematic review using the consensus-based standards for the selection of health measurement instruments (COSMIN) checklist
    Sharawi, N.
    Klima, L.
    Shah, R.
    Blake, L.
    Carvalho, B.
    Sultan, P.
    ANAESTHESIA, 2019, : 1439 - 1455
  • [45] WHAT CAN THE PATIENT WITH CHRONIC END-STAGE HEART FAILURE EXPECT FROM A LONG-TERM LEFT VENTRICULAR ASSIST DEVICE? A SYSTEMATIC REVIEW OF CURRENT EVIDENCE
    Sas, G.
    Lambert, L. J.
    Boothroyd, L. J.
    Ducharme, A.
    Charbonneau, E.
    Carrier, M.
    Cecere, R.
    Guertin, J. R.
    Morin, J. E.
    Bogaty, P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S337 - S338
  • [46] Assessment of Patient-Reported Outcome Measures for Maternal Postpartum Depression Using the Consensus-Based Standards for the Selection of Health Measurement Instruments Guideline: A Systematic Review (vol 5, e2214885. 2022)
    Sultan, P.
    Ando, K.
    Elkhateb, R.
    JAMA NETWORK OPEN, 2022, 5 (08)